28.8 C
New York
Sunday, June 14, 2026

Tag: six months

CORRECTION: Pro Kapital Council approved Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited)

The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million.
Therefore, we are publishing again both the corrected notice and the amended report.

CORRECTION: Pro Kapital Council approved Consolidated Interim Report for Ii Quarter and 6 Months of 2025 (Unaudited)

The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million.
Therefore, we are publishing again both the corrected notice and the amended report.

GlobalTech Corporation Announces Second Quarter 2025 Results

RENO, Nev., Aug. 14, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTCID:GTLK) (“GlobalTech” or the “Company”), a technology holding company specializing in artificial intelligence (AI) and big data solutions, today announced its financial results for the second quarter ended June 30, 2025.

Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation

 Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach

HLS Therapeutics Announces Q2 2025 Financial Results

Adjusted EBITDA grew 21% in Q2 and 29% year-to-date Cash from operations grew 83% in Q2 and 147% year-to-dateMade principal repayments on the Company's...

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 –

AIMIA REPORTS SECOND QUARTER 2025 RESULTS; RE-ITERATES AEBITDA GUIDANCE AND LOWERS HOLDCO COST TARGET FOR THE YEAR

TORONTO, Aug. 14, 2025 /CNW/ - Aimia Inc, (TSX: AIM) ("Aimia" or the "Company"), today reported its financial results for the three and six months...

Allot Announces Second Quarter 2025 Financial Results

Exceptionally strong 73% year-over-year growth in SECaaS ARR; raising full year guidance HOD HASHARON, Israel, Aug. 14, 2025 /PRNewswire/ -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT),...

Battalion Oil Corporation Announces Second Quarter 2025 Financial and Operating Results

HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the second quarter of 2025.

22nd Century Group Reports Second Quarter 2025 Financial Results

VLN® Early Adoption Commercial Activity Expands with Two Partner Brand Launches in Progress – Smoker Friendly and Pinnacle

AB KN Energies (KN) will hold an Investor Conference Webinar to introduce unaudited financial results for the six months of 2025

KN invites shareholders, investors, analysts, and other stakeholders to join its investor conference webinar scheduled on August 22nd of 2025 at 9.00 am (EET). The presentation will be held in English.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSix months